Lifecore Biomedical Inc’s filing revealed that its Chief Executive Officer Josephs Paul acquired Company’s shares for reported $97580.0 on Jan 08 ’25. In the deal valued at $5.74 per share,17,000 shares were bought. As a result of this transaction, Josephs Paul now holds 559,717 shares worth roughly $3.94 million.
Then, Morberg John D bought 10,000 shares, generating $71,691 in total proceeds.
Before that, Morberg John D bought 30,990 shares. Lifecore Biomedical Inc shares valued at $205,803 were divested by the Former officer at a price of $6.64 per share.
Craig Hallum initiated its Lifecore Biomedical Inc [LFCR] rating to a Buy in a research note published on September 05, 2024; the price target was $8. A number of analysts have revised their coverage, including Barrington Research’s analysts, who decreased its forecast for the stock in late August from “an Outperform” to “a Mkt perform”. Stephens also remained covering LFCR and has decreased its forecast on March 20, 2023 with a “an Equal-weight” recommendation from previously “an Overweight” rating.
Price Performance Review of LFCR
On monday, Lifecore Biomedical Inc [NASDAQ:LFCR] saw its stock jump 2.77% to $7.04. Over the last five days, the stock has gained 6.67%. Lifecore Biomedical Inc shares have fallen nearly -5.25% since the year began. Nevertheless, the stocks have risen 36.17% over the past one year. While a 52-week high of $7.99 was reached on 01/03/25, a 52-week low of $3.68 was recorded on 02/24/25. SMA at 50 days reached $6.16, while 200 days put it at $5.88.
Levels Of Support And Resistance For LFCR Stock
The 24-hour chart illustrates a support level at 6.71, which if violated will result in even more drops to 6.38. On the upside, there is a resistance level at 7.28. A further resistance level may holdings at 7.52. The Relative Strength Index (RSI) on the 14-day chart is 71.67, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.29, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 15.15%. Stochastics %K at 87.19% indicates the stock is a selling.
How much short interest is there in Lifecore Biomedical Inc?
A steep rise in short interest was recorded in Lifecore Biomedical Inc stocks on 2025-03-14, growing by 55384.0 shares to a total of 2.46 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 2.4 million shares. There was a rise of 2.25%, which implies that there is a positive sentiment for the stock.
